# POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock

> **NCT03953404** · — · UNKNOWN · sponsor: **St. Luke's Hospital, Pennsylvania** · enrollment: 450 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** SPLA2-IIA

## Key facts

- **NCT ID:** NCT03953404
- **Lead sponsor:** St. Luke's Hospital, Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-14
- **Primary completion:** 2020-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2019-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953404, "POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03953404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*